Orforglipron LY-3502970 Weight Loss Powder | CAS 2212020-52-3 | GLP-1 Receptor Agonist

Orforglipron (LY-3502970) is a novel GLP-1 receptor agonist developed for weight management and metabolic research applications. This white powder compound with CAS number 2212020-52-3 represents a significant advancement in peptide-based therapies for obesity and related metabolic disorders.

The mechanism of action involves activation of GLP-1 receptors, which play crucial roles in glucose metabolism and appetite regulation. Research indicates this compound may offer multiple metabolic benefits including improved glycemic control and potential weight reduction effects.

Key research applications include:

• Investigating mechanisms of appetite regulation
• Studying glucose metabolism pathways
• Exploring novel obesity treatment approaches
• Metabolic syndrome research
• Diabetes-related studies

This pharmaceutical-grade material is supplied as a lyophilized powder with guaranteed purity ≥99%. Proper handling and storage according to laboratory protocols is essential to maintain compound stability.

Note: This product is intended for research purposes only in laboratory settings. Not for human consumption or diagnostic use.